Van ECK Associates Corp reduced its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 21.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 344,960 shares of the company's sto